Cellestial Health is a pharmaceutical spin-out from the University of Cambridge developing small molecule drugs that protect an overlooked half of the brain – networks of brain cells called astrocytes – to stop progression of Parkinson's and other neurological conditions.
For conference production and speaking opportunites:
For sponsorship and exhibition opportunities: